Onconic Therapeutics Inc.
Clinical trials sponsored by Onconic Therapeutics Inc., explained in plain language.
-
New combo therapy targets tough pancreatic cancer
Disease control Recruiting nowThis study is for people with advanced pancreatic cancer that cannot be removed by surgery or has spread. It tests a new drug called JPI-547 given together with standard chemotherapy. The goal is to find the best dose and see if the combination is safe and helps shrink or control…
Phase: PHASE1, PHASE2 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 11:38 UTC
-
New drug JP-1366 put through safety check with heart meds
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called JP-1366 in 96 healthy adults to see if it safely interacts with common heart medications like clopidogrel, aspirin, atorvastatin, and apixaban. The goal is to measure how the body processes these drugs together and check for any…
Phase: PHASE1 • Sponsor: Onconic Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC